You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, ALK Gene Rearrangement Positive Trial in France (RNAseq)

Recruiting
  • Non-small Cell Lung Cancer
  • ALK Gene Rearrangement Positive
  • RNAseq
  • Saint-Denis, La Réunion, France
  • +44 more
Nov 4, 2021

Non Small Cell Lung Cancer Trial in Worldwide (Taletrectinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Beverly Hills, California
  • +58 more
Dec 13, 2022

To Explore Diversity of Intestinal Flora in Advanced HCC Combin

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
    • (no location specified)
    Sep 22, 2019

    Hepatocellular Cancer, Liver Cancer Trial in United States (OMP-54F28 with Sorafenib)

    Completed
    • Hepatocellular Cancer
    • Liver Cancer
    • OMP-54F28 with Sorafenib
    • Los Angeles, California
    • +5 more
    Aug 10, 2020

    Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer,

    Recruiting
    • Locally Advanced or Metastatic ER+ HER2- Breast Cancer
    • +2 more
    • Scottsdale, Arizona
    • +45 more
    Dec 11, 2022

    NSCLC NSCLC Trial in Worldwide (Durvalumab, Placebo for Olaparib, Olaparib)

    Active, not recruiting
    Has Results
    • Non-small Cell Lung Cancer NSCLC
    • Bonita Springs, Florida
    • +67 more
    Nov 15, 2022

    NGS Combined With RNAseq on Tumor Immune Escape in NSCLC

    Unknown status
    • Non-small Cell Lung Cancer
    • Time
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Mar 22, 2020

    Squamous Cell Carcinoma, Esophageal Cancer, Perioperative Period Trial in Zhengzhou (teripalimab plus chemo, chemo plus

    Recruiting
    • Squamous Cell Carcinoma
    • +2 more
    • teripalimab plus chemotherapy
    • chemotherapy plus teripalimab
    • Zhengzhou, Henan, China
      Affiliated Cancer Hospital of Zhengzhou University & Henan Cance
    Dec 10, 2019

    Hepatocellular Carcinoma Trial (Pirarubicin, Oxaliplatin, Lipiodol)

    Withdrawn
    • Hepatocellular Carcinoma
    • (no location specified)
    Jun 1, 2019

    Non-squamous NSCLC Trial in Xian (Anlotinib)

    Unknown status
    • Non-squamous NSCLC
    • Xian, Shanxi, China
      Shaanxi Provincial Cancer Hospital
    Apr 1, 2020

    Renal Cell Carcinoma, Neuroendocrine Tumours Trial in Edmonton (18F-FAZA PET Imaging)

    Terminated
    • Renal Cell Carcinoma
    • Neuroendocrine Tumours
    • 18F-FAZA PET Imaging
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Aug 21, 2019

    Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma, Stage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and

    Withdrawn
    • Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma
    • +4 more
    • Atlanta, Georgia
    • +1 more
    Aug 26, 2019

    Clear Cell Renal Cell Carcinoma Trial in Lund (Ioflupane I123)

    Terminated
    Has Results
    • Clear Cell Renal Cell Carcinoma
    • Ioflupane I123
    • Lund, Sweden
      Skåne University hospital SUS
    Mar 25, 2019

    Oral Mucositis Trial in United States (RRx-001, Cisplatin for injection, Radiation Therapy)

    Completed
    • Oral Mucositis
    • Santa Monica, California
    • +11 more
    Jan 7, 2021

    Solid Tumors Trial in Worldwide (Avelumab)

    Completed
    Has Results
    • Solid Tumors
    • Goodyear, Arizona
    • +73 more
    Oct 26, 2021

    Head and Neck Tumors Trial in Saint Louis (drug, radiation, procedure)

    Completed
    Has Results
    • Head and Neck Neoplasms
    • paclitaxel albumin-stabilized nanoparticle formulation
    • +5 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Sep 9, 2020

    Recurrent Squamous Cell Carcinoma of the Head or Neck, Metastatic Squamous Cell Carcinoma of the Head or Neck, Squamous Cell

    Withdrawn
    • Recurrent Squamous Cell Carcinoma of the Head or Neck
    • +2 more
    • (no location specified)
    Jun 17, 2019

    Carcinoma, Pancreatic Trial in Shanghai (Transcatheter arterial infusion, Intravenous chemo, Gemcitabine)

    Unknown status
    • Carcinoma, Pancreatic
    • Transcatheter arterial infusion
    • +3 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Mar 3, 2020

    Advanced Adult Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v7 Trial in

    Completed
    Has Results
    • Advanced Adult Hepatocellular Carcinoma
    • +9 more
    • Doxorubicin Hydrochloride
    • +3 more
    • Birmingham, Alabama
    • +672 more
    Aug 3, 2022

    Cancer, Hepatocellular, Radiotherapy Side Effect Trial (Multiparametric MRI scans, Multiparametric MRI scans + HepQuantShunt

    Not yet recruiting
    • Cancer, Hepatocellular
    • Radiotherapy Side Effect
    • Multiparametric MRI scans
    • Multiparametric MRI scans + HepQuantShunt Test
    • (no location specified)
    Nov 17, 2023

    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Carcinoma Trial in Beijing (Icotinib)

    Completed
    • Adenocarcinoma of the Gastroesophageal Junction
    • Esophageal Carcinoma
    • Beijing, Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    Jul 2, 2019

    Intrahepatic Cholangiocarcinoma, Combined Hepatocellular and Cholangiocarcinoma Trial in Worldwide (derazantinib)

    Recruiting
    • Intrahepatic Cholangiocarcinoma
    • Combined Hepatocellular and Cholangiocarcinoma
    • Phoenix, Arizona
    • +40 more
    Mar 7, 2022

    Lung Cancer, Lung Diseases, Lung Cancer, Nonsmall Cell Trial in Toronto (Chest Xray, No daily chest xray)

    Completed
    • Lung Cancer
    • +4 more
    • Chest Xray
    • No daily chest xray
    • Toronto, Ontario, Canada
      Toronto General Hospital
    Apr 29, 2020

    Liver Cancer Trial in Guangzhou (Indocyanine green for injection)

    Recruiting
    • Liver Cancer
    • Indocyanine green for injection
    • Guangzhou, Guangdong, China
      Zhujiang Hospital of Southern Medical University
    Jan 21, 2022

    Squamous Cell Carcinoma of the Head and Neck Trial in Denver (Olaparib, Cetuximab, Radiation Therapy)

    Completed
    Has Results
    • Squamous Cell Carcinoma of the Head and Neck
    • Denver, Colorado
      University of Colorado Denver
    Sep 20, 2019